In this issue:
Complete histological normalisation reduces relapse risk in UC in complete endoscopic remission
Tofacitinib dose de-escalation and escalation in UC
Healthcare costs of IBD in Europe
Global burden of IBD
Etrasimod for UC
Efficacy and safety of anti-TNF agents for internal fistulising CD
Test to monitor endoscopic activity in CD based on serum protein levels
Mirikizumab for UC
CRC in CD
Please login below to download this issue (PDF)